Topic:
Clinical IT
Latest Headlines
Latest Headlines
Trials software outfit BioClinica reports annual results (for the last time?)
BioClinica told investors that it won't be issuing annual guidance for 2013. That's because the provider of clinical trials software and core lab imaging is being bought in a $123 million private equity deal.
Clinical trials software player agrees to $123M buyout
The New York-based private equity player JLL Partners has struck a deal to buy the growing eClinical outfit BioClinica for $7.25 per share or about $123 million, paying a 23.2% premium on the average closing price of the company's stock for the past 90 days.
UPDATED: GoBalto wants to save Big Pharma from bungling one big thing
Behind the huge and scary numbers that accompany the costs of drug development, there are various holes and dysfunctional practices in the process of bringing a new drug to market.
New chief named for Perceptive Informatics
The CRO giant Parexel International ($PRXL) announced a changing of the guard at its Perceptive Informatics unit, which provides electronic clinical trials (eClinical) software. Healthcare software veteran Xavier Flinois is taking over for Steve Kent as president of Perceptive, the parent company said this morning.
Software outfit tackles multibillion-dollar bugaboo in clinical trials
The 800-pound gorilla in pharma companies' oft-criticized R&D budgets is the cost of large clinical trials. In the race to provide ways to trim the big expense, CluePoints has debuted with a software and service to identify potential errors in clinical trials data and derisk regulatory submissions.
Will AthenaHealth's $293 million deal for mobile apps outfit matter to pharma?
Epocrates has caught the attention of pharma players with trendy mobile apps for physicians that let them look up info on prescription meds. AthenaHealth, an electronic health records outfit, has bet on the app provider in a $293 million buyout of the company.
Consortium sifting through MS data to find new endpoint
A consortium is targeting the discovery of a new primary endpoint for multiple sclerosis trials by analyzing data from current studies. The alliance hopes that by sifting through the wealth of data generated by MS trials, they can find a clinician-reported outcome measure of disability.
Pfizer, others seek untapped potential in virtual clinical trials
In an article in Life Science Leader , Pfizer's Craig Lipset talked about how the company's virtual clinical trial rolled out many new tech tools at once to trial the overall bladder drug Detrol, with some setbacks along the way.
Speech software spots most Parkinson's cases
Software offers a potential new way to quickly identify Parkinson's disease, the common neurological disorder that afflicts Michael J. Fox and hundreds of thousands of other Americans.
Cmed expanding in North Carolina as CRO-tech combos take off
Cmed is getting bigger. The U.K.-based provider of contract research and electronic clinical trials services to pharma companies is moving into a new office in Durham, NC, that offers nearly 50% more space than its previous facility there.
